Adaptive Biotechnologies (ADPT) Other financing activities (2018 - 2019)

Adaptive Biotechnologies (ADPT) posted Other financing activities of $1.6 million for Q3 2019, down 51.69% sequentially from $3.4 million in Q2 2019, and up 12407.69% YoY from N/an in Q3 2018.

Adaptive Biotechnologies (ADPT) Other financing activities (2018 - 2019) Analysis & Trends

Adaptive Biotechnologies (ADPT) has 2 years of Other financing activities data on file, last reported at $1.6 million in Q3 2019.

  • Quarterly Other financing activities rose 12407.69% year-over-year to $1.6 million in Q3 2019, while the trailing twelve-month figure through Dec 2020 was $5.0 million (changed 0.12% YoY) and the FY2020 annual result came in at $321000.0, down 93.56% from the prior year.
  • Other financing activities slipped to $1.6 million in Q3 2019 per ADPT's latest filing, from $3.4 million in the prior quarter.
  • The five-year high for Other financing activities was $3.4 million in Q2 2019, with the low at -$23000.0 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Adaptive Biotechnologies 3.48 Bn 3.27 Bn 52.17 Mn

Historic Data

Download Data
DateValue
Sep 30, 2019 1.63 Mn
Sep 30, 2019 1.63 Mn
Jun 30, 2019 3.37 Mn
Jun 30, 2019 3.37 Mn
Mar 31, 2019 -6,000.00
Mar 31, 2019 -6,000.00
Dec 31, 2018 -23,000.00
Dec 31, 2018 -23,000.00
Sep 30, 2018 13,000.00
Sep 30, 2018 13,000.00
Jun 30, 2018 1,000.00
Jun 30, 2018 1,000.00